IL33 and cardiovascular disorder: Similarly, it has been found that the prothrombotic state in patients with cardiovascular disease is associated with increased TF expression in monocytes and elevated levels of circulating EVs, and that interleukin-33 (IL-33) induces differential TF expression and activity in monocyte subpopulations, further promoting the release of EVs [42].